At SciX, Jay Kitt discusses a project applying Raman spectroscopy to PFAS analysis, the mentoring role he found after leaving traditional academia, and why machine learning could unlock the biochemical information in vibrational spectra.
News|Videos|February 11, 2025
Using Automated Raman Microspectroscopy to Detect Microplastics in Potable Water
Author(s)Will Wetzel
In part 2 of our interview with Oskar Hagelskjaer of Microplastic Solution, he discusses the benefits of using automated Raman microspectroscopy to detect and analyze microplastics in drinking water.
Advertisement
Advertisement
Raman micro-spectroscopy is a highly effective method for identifying and classifying cancer cells and tissues. Studies have shown good accuracy in detecting bladder, cervical, and oral cancer compared to standard pathology (1). However, despite being non-invasive and cost-effective, its slow recording time and lack of reproducibility have hindered its clinical adoption (1).
Related to this article
A recent conversation with Kevin Wilkinson, a professor of environmental chemistry at the Université de Montréal, sheds light on why no single signature can separate engineered nanoparticles from natural ones.
Mammograms can find breast microcalcifications but can’t tell whether they are likely benign or malignant.
In a SciX interview, Marc Porter covered a lot of ground, from a student-driven pivot into immunoassays to a baseball analogy for Stokes and anti-Stokes scattering, and shares the open questions he is still chasing.
Laser-induced breakdown spectroscopy (LIBS) is being used in numerous application areas, including environmental monitoring, cultural heritage, and space exploration.
Amy Colleran, a Postdoctoral Researcher in the Centre of Metabolomics Research at the University of Liverpool, is exploring how to detect volatile organic compounds by bubbling them directly into colloidal silver and gold nanoparticles.
In this interview segment from SciX, Juergen Popp explains why molecular “twins” built from optical measurements could reach patients within a decade, provided the field builds the regulatory, computing, and standards ecosystem around the technology.
At SciX, Jay Kitt describes the experiment he ran on his own that launched his cytochrome c research, and explains why putting a number on peptide–lipid interactions matters.
Advertisement
Advertisement